Question 1

Does ProShare Advisors own ARWR stock?

Accepted Answer

Yes. As of its Q3 2026 13F, ProShare Advisors holds 10,526 shares of ARWR (Arrowhead Pharmaceuticals), worth $688,927.

Question 2

How many shares of ARWR does ProShare Advisors own?

Accepted Answer

As of its Q3 2026 13F, ProShare Advisors holds 10,526 shares of ARWR (Arrowhead Pharmaceuticals).

Question 3

What is ProShare Advisors' ARWR position worth?

Accepted Answer

As of its Q3 2026 13F, ProShare Advisors' ARWR position is worth $688,927.

Question 4

Is ProShare Advisors buying or selling ARWR?

Accepted Answer

In Q3 2026, ProShare Advisors increased its ARWR position by 92 shares (+0.9%).

Question 5

When did ProShare Advisors first buy ARWR?

Accepted Answer

ProShare Advisors already held ARWR in its Q4 2018 13F, the earliest on record, and has listed it in 32 quarterly 13F filings.

Quarter	Action	Shares	Change	Value	Weight	Price	Conviction
2026-Q3 Latest	Increased	10,526	+0.9%	$688,927	0.0%	$65.45	25
2026-Q2	Decreased	10,434	-66.9%	$850,475	0.0%	$81.51	0
2026-Q1	Decreased	31,498	-1.1%	$2M	0.0%	$62.70	0
2025-Q4	Increased	31,855	+13.9%	$2.1M	0.0%	$66.39	30
2025-Q3	Decreased	27,958	-13.1%	$964,271	0.0%	$34.49	0
2025-Q2	Decreased	32,176	-5.2%	$508,381	0.0%	$15.80	0
2025-Q1	Decreased	33,927	-25.2%	$432,231	0.0%	$12.74	0
2024-Q4	Increased	45,330	+28.3%	$852,204	0.0%	$18.80	31
2024-Q3	Increased	35,325	+21.5%	$684,244	0.0%	$19.37	29